A novel ATP7B gene mutation in a liver failure patient with normal ceruloplasmin and low serum alkaline phosphatase.

[1]  M. Schilsky,et al.  Wilson Disease: Pathogenesis and Clinical Considerations in Diagnosis and Treatment , 2011, Seminars in liver disease.

[2]  Kisha Mitchell,et al.  Pathology of the Liver in Copper Overload , 2011, Seminars in liver disease.

[3]  N. Oosthuizen.  Undetectable serum alkaline phosphatase activity in a patient with fulminant hepatic failure and hemolytic anemia. , 2011, Clinical chemistry.

[4]  D. Cassio,et al.  Molecular pathology of Wilson's disease: a brief. , 2010, Journal of hepatology.

[5]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[6]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[7]  William M. Lee,et al.  Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests , 2008, Hepatology.

[8]  M. T. Pellecchia,et al.  Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin. , 2007, Genetic testing.

[9]  K. Ashkan,et al.  Wilson's disease , 2007, The Lancet.

[10]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[11]  D. Cox,et al.  Diagnosis and phenotypic classification of Wilson disease 1 , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[12]  A. Herneth,et al.  Wilson's disease in patients presenting with liver disease: a diagnostic challenge. , 1997, Gastroenterology.

[13]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[14]  G. Zang,et al.  RESEARCH ARTICLE Open Access Clinical and molecular characterization of Wilson’s disease in China: identification of 14 novel mutations , 2022 .